I don't think it'll drop to a penny-it shouldn't.
The IP and assets are worth .10-.12 pps. The R/S did help immensely with lowering the share pool, and the price was right to drop 60%, back into something closer to fair market value. The shareholders are fortunate that the product that Acology purchased from Medtainer, is extremely marketable, and instantly recognizable (not as a brand, but as a function of being a grinder)... so it would be really difficult for management to screw that up... But, i wouldn't even be considering a re-buy until I see the subsequent (still unfiled) 10Q's. The 10-k and letter was enough of shitshow to remind me of two things: Management is lacking business skill across the board, and the product is still selling in spite on their ineptitude, so that's a silver lining. They don't have an obscene amount of debt (another plus), the R/S brought the share pool back in line with company size and performance (painful, but necessary), and (hopefully, the purchase of Medtainer by Acology is something that has now been completed (with full audit) (another big plus because even though it took a goddamn year and a half, at least we don't have that spectre hanging over us (shareholders) like a shadow anymore.
So, there are some good things to help balance out the bad, unfortunate that the strength of the product is equally outweighed (significantly) by the weaknesses of management.
Full disclosure, I dumped 20k shares when it hit .20. I still have a relatively decent position, but I won't do anything til they show me they know how to do something.
